Parenteral norovirus vaccine formulations
US10675341B2 · kind B2 · utility
3Cited by
31References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 8, 2017 |
| Grant date | Jun 9, 2020 |
| Priority date | — |
| Expiry date | Dec 8, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/16034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to single dose parental vaccine compositions comprising mixtures of monovalent Norovirus virus-like particles. Methods of conferring protective immunity against Norovirus infections in a human subject by administering such compositions are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.